Nantahala Capital Management, LLC Keros Therapeutics, Inc. Call Options Transaction History

Nantahala Capital Management, LLC

  • $1.55 Billion
  • Q1 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2023

Feb 14, 2024
SELL
$27.12 - $41.05 $24,408 - $36,945
-900 Reduced 7.32%
11,400 $453,000
Q1 2023

May 15, 2023
SELL
$41.44 - $59.32 $1.23 Million - $1.76 Million
-29,600 Reduced 70.64%
12,300 $525,000
Q1 2022

May 13, 2022
BUY
$42.12 - $59.36 $92,664 - $130,592
2,200 Added 5.54%
41,900 $2.28 Million
Q4 2021

Feb 14, 2022
BUY
$36.95 - $62.89 $1.47 Million - $2.5 Million
39,700 New
39,700 $2.32 Million

Others Institutions Holding KROS

# of Institutions
153
Shares Held
26.7M
Call Options Held
47.6K
Put Options Held
34.5K
View Full List

About Keros Therapeutics, Inc.

KROS Quotes by TradingView
  • Ticker KROS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,757,000
  • Market Cap $1.18B
  • Description
  • Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...
More about KROS
Track This Portfolio

Track Nantahala Capital Management, LLC Portfolio

Follow Nantahala Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nantahala Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nantahala Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email